نتائج البحث

| routes_of_administration = Oral tablets, 3.75 mg (<small>[[United Kingdom|UK]]</small>), 5 or 7.5 mg

| pregnancy_category = A <small>([[Australia|Au]])</small>, B <small>([[United States|U.S.]])</small> ...u]])</small>, POM <small>([[United Kingdom|UK]])</small>, ℞-only <small>([[United States|U.S.]])</small>

| pregnancy_category = B1 <small>([[Australia|Au]])</small>, B <small>([[United States|U.S.]])</small> | legal_status = S3/S4 <small>(Au)</small>, POM/OTC <small>([[United Kingdom|UK]])</small>,<br />OTC/℞-only <small>(U.S.)</small>

...ickly succeeded using petroleum or coal tar and a process developed at the United States' National Institutes of Health. ...land]], [[Romania]], [[Russia]], [[Sweden]], the [[United Kingdom]], the [[United States]], and many other countries, codeine is regulated under various [[Dr

| legal_status = Ocular P, else POM <small>([[United Kingdom|UK]])</small>

...by GlaxoSmithKline in Canada, the U.S., Australia, Ireland and the United Kingdom, Azamun in Finland and Imurel in Scandinavia and France, among others).

...myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98 (5): 1312-20, 2001.</ref>

...andling|date=2007|publisher=Birkbeck, University of London|location=United Kingdom|url=http://www.bbk.ac.uk/so/policies/liqn2|accessdate=2012-02-08}}</ref>

...lyomavirus |journal=Proceedings of the National Academy of Sciences of the United States of America |volume=105 |issue=42 |pages=16272–7 |year=2008 |month= |title=Measles in the United Kingdom: can we eradicate it by 2010?